Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DM6L5TR)

Drug Name
EGEN-001 Drug Info
Indication
Disease Entry ICD 11 Status REF
Fallopian tube cancer 2C74 Phase 2 [1]
Ovarian cancer 2C73 Phase 2 [1]
Peritoneal cancer 2C51.Z Phase 2 [1]
Cross-matching ID
TTD Drug ID
DM6L5TR

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interleukin-12 beta (IL12B) TTGW72V IL12B_HUMAN Modulator [2]

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Fallopian tube cancer
ICD Disease Classification 2C74
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Interleukin-12 beta (IL12B) DTT IL12B 1.08E-01 0.13 0.17
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 ClinicalTrials.gov (NCT01118052) EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer. U.S. National Institutes ofHealth.
2 National Cancer Institute Drug Dictionary (drug id 454593).